Physician profile
Gretchen E Black
NPI 1720075773
$4,520.84
in general payments reported to CMS, 2019-2025
39 companies · $664 in 2025
The $664 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $635 · 2020: $134 · 2021: $74.00 · 2022: $577 · 2023: $1,102 · 2024: $1,335 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,101.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,243.42 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $521.75 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Corium, LLC | $371.66 | 2022-2024 | Azstarys |
| Merck Sharp & Dohme LLC | $255.47 | 2022-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Ironshore Pharmaceuticals INC. | $233.47 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $220.29 | 2019-2025 | |
| Neos Therapeutics, LP | $182.24 | 2019-2023 | Cotempla Xr-Odt |
| Tris Pharma INC | $144.92 | 2019-2022 | |
| Novo Nordisk INC | $134.41 | 2020-2025 | Wegovy, Rybelsus |
| Cranial Technologies, INC | $94.12 | 2019-2025 | Doc Band |
| Ultragenyx Pharmaceutical INC. | $87.11 | 2019-2025 | Dojolvi |
| Sanofi-Aventis U.S. LLC | $80.97 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.61 | 2022 | |
| Abbvie INC. | $71.92 | 2021-2022 | |
| Amgen INC. | $69.98 | 2019-2024 | Repatha, Otezla |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.